GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer-Reference-Cited by-同舟云学术

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Published:2012-11-15 Issue:22 Volume:11 Page:4203-4210
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Rick Ferenc G.,Seitz Stephan,Schally Andrew V.,Szalontay Luca,Krishan Awtar,Datz Christian,Stadlmayr Andreas,Buchholz Stefan,Block Norman L.,Hohla Florian

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.22498

Reference44 articles.

1. Global cancer statistics

2. Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

3. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

4. Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

5. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Hormone-Releasing Hormone as Potential Diagnostic and Therapeutic Target in Colorectal Cancer;Current Cancer Therapy Reviews;2024-03-12

2. Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer;Current Cancer Drug Targets;2023-05

3. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma;International Journal of Molecular Sciences;2022-09-24

4. Gamma-glutamyltransferase of Helicobacter pylori alters the proliferation, migration, and pluripotency of mesenchymal stem cells by affecting metabolism and methylation status;Journal of Microbiology;2022-04-18

5. The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin;Journal of Cellular and Molecular Medicine;2021-12-06